August 17th 2023
A daily dose of clinical news on Patient Care you may have missed.
September 30th 2014
Hemolytic Disease of the Newborn
April 1st 2008An 8-week-old boy is brought for evaluation of gradually worsening yellow skin discoloration of about 1 week's duration. His parents report that he has had constipation for the past several days; before that, he had green diarrhea and occasionally spit up after breast-feeding.
Scurvy Presenting as Weakness, Arthralgia, Myalgia, and Rash
March 2nd 2008For 2 months, a 68-year-old man had had progressive weakness, arthralgia, myalgia, and a rash on the arms and legs. Closer examination of the rash showed petechial lesions and follicular hyperkeratosis with perifollicular hemorrhage and corkscrew hairs. The patient also had poor dentition and swollen, purple, spongy gingivae.
Weakness: Guidelines for a Cost-Effective Workup
December 1st 2007The differential diagnosis of generalized weakness is enormous; it includes disorders at all levels of the neur-axis. A variety of electrophysiological, pathological, radiographic, and other laboratory studies may be indicated depending on the specific diagnostic possibilities; costs can be controlled if such investigations are selected judiciously.
Sudden Loss of Consciousness in an Elderly Woman
October 1st 2007A comatose 82-year-old woman is brought to the emergency department. Her husband reports that after dinner she began to have difficulty in speaking, lost consciousness, and fell to the floor. He tried to rouse her, but was unsuccessful and called for an ambulance.
Frequent Nocturnal Dialysis Offers Cardiac and Other Benefits
September 18th 2007CALGARY, Alberta -- Nocturnal dialysis at home six times a week markedly reduced left ventricular hypertrophy in patients with end-stage renal disease compared with conventional treatment, according to a preliminary study.
Mixed Results for Epoetin (Epogen or Procrit) in Critically Ill Patients
September 5th 2007LEBANON, N.H. -- Epoetin alfa (Epogen or Procrit) failed to reduce red-cell transfusions in ICU patients but appeared to decrease mortality in trauma patients, researchers reported. Still, the drug increased thrombotic events.
New Lymphadenopathy in a Woman With a History of Colon Cancer
September 1st 2007A 47-year-old woman who recently completed adjuvant chemotherapy for colon cancer has painless cervical lymphadenopathy of 1 to 2 cm. She has no fever, sore throat, cough, or unexplained weight loss, and she denies exposure to ill persons or animals.
Heart Failure: Part 2, Update on Therapeutic Options
August 1st 2007ABSTRACT: Angiotensin-converting enzyme inhibitors and ß-blockers are the cornerstone of heart failure medical therapy; unless contraindicated, start these agents as soon as possible after volume status has been optimized. Aldosterone receptor antagonists, angiotensin-receptor blockers, and a fixed-dose combination of hydralazine and isosorbide dinitrate (the last recommended especially for African Americans) can be used as add-on therapy. Prophylactic implantable cardioverter defibrillators reduce long-term mortality in symptomatic patients with a left ventricular ejection fraction (LVEF) of 35% or less. Cardiac resynchronization therapy improves symptoms and ventricular remodeling in some patients; indications include wide (more than 20 milliseconds) QRS complex on ECG, impaired LVEF (35% or less), and advanced heart failure symptoms (NYHA classes III and IV) despite optimal drug therapy. Measurement of natriuretic peptides and impedance cardiography both show promise for monitoring patients with heart failure and for guiding therapy, but definitive data to justify their routine use are still lacking.
Combined Chemotherapy Improves CLL Outcomes but Not Survival
July 20th 2007SUTTON, England -- Progression-free survival in chronic lymphocytic leukemia was extended significantly over monotherapy by combining fludarabine and cyclophosphamide, found an international study. But overall survival did not improve.
Elevated Hematocrit in Man Receiving Hemodialysis
June 1st 2007A 50-year-old man with end-stage renal disease secondary to long-standing hypertension had an elevated hematocrit and progressively increasing hemoglobin levels. For the past 7 years, he had been receiving hemodialysis 3 times a week. He denied headache, flushing, easy bruising, bleeding, nausea, vomiting, chest pain, dyspnea, and other symptoms. He was not receiving exogenous erythropoietin.